125 participants
Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2006-05-03
- Start Date:
- 2002-11-30
Conditions
- Age-Related Macular Degeneration
Interventions
- DRUG
No Results Yet